In preparation for launch, Swedish/Danish Acarix AB’s (publ) (“Acarix”) CADScor®System will be on display at the British Cardiovascular Society Annual Meeting in Manchester, June 5-7. Delegates will have the opportunity to review first results from a study that was presented at the American College of Cardiology Annual Scientific Meeting held in Washington, March 17-19, 2017 showing that CADScor®System non-invasively rules out Coronary Artery Disease (CAD) with 97% negative predictive value. According to figures from the British Heart Foundation, cardiovascular disease accounts for around 26% of all deaths in the UK, some 116,000 per year with earlier diagnosis being a clear priority for the NHS.

Download Press Release (PDF)